EUVIMEDEUVIMED entdecken
Open Access

Paclitaxel Efficacy in Dialysis‐Dependent Peripheral Artery Disease: A National Cohort Analysis

Chen-Yu Huang iD, Hsu-Ping Wu iD, Wen-Jung Chung iD, Shu-Kai Hsueh, Donna Shu-Han Lin iD, Po-Chao Hsu iD, Chun-Chi Chen iD, Jen-Kuang Lee iD, Chi-Hung Huang iD, Hsuan-Li Huang iD

Journal of the American Heart Association · 21.07.2026 · 15 (14)

DOI: 10.1161/jaha.126.050231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 21.07.2026. Verfasst von Chen-Yu Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center Cathay General Hospital Taipei Taiwan. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Renal Dialysis, Paclitaxel, Endovascular Procedures. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients undergoing dialysis have a significant risk of peripheral artery disease, limb amputation, and mortality. Paclitaxel‐coated devices (PCDs) are used to reduce restenosis after endovascular therapy, but their safety and efficacy in a dialysis‐dependent population remain unclear. We aimed to evaluate the association between PCDs and major clinical outcomes in patients with maintenance dialysis undergoing endovascular therapy for symptomatic peripheral artery disease.

Methods

We conducted a nationwide retrospective cohort analysis using the National Health Insurance Research Database in Taiwan. Patients under dialysis receiving endovascular therapy between May 2016 and December 2022 were included. Patients were categorized into PCD and non‐PCD groups during the index procedure. Propensity score matching was performed to balance baseline characteristics. The primary outcome was defined as the composite of lower limb amputation or all‐cause mortality. Cardiovascular outcomes and clinical‐driven reintervention were secondary outcomes.

Results

Among 10 235 eligible patients, 1169 (11.4%) received PCDs. After 1:3 matching, 1160 and 3480 patients in the PCD and non‐PCD groups were analyzed. PCD use was associated with a significantly lower risk of the primary outcome (47.6% versus 52.2%; hazard ratio [HR], 0.85 [95% CI, 0.77–0.93]). Risks of amputation (20.7% versus 23.8%; subdistribution HR, 0.84 [95% CI, 0.73–0.97]) and all‐cause mortality (35.9% versus 38.9%; HR, 0.87 [95% CI, 0.78–0.97]) were also significantly lower with PCD use. Cardiovascular outcomes and clinical‐driven reintervention were similar between groups.

Conclusions

Use of PCD in dialysis‐dependent patients undergoing endovascular therapy for peripheral artery disease was associated with reduced risk of the composite outcome of amputation and all‐cause mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseRenal DialysisPaclitaxelEndovascular ProceduresDrug-Eluting StentsHumansRetrospective StudiesAgedFemaleAmputation, SurgicalMaleTaiwanTreatment OutcomeMiddle AgedRisk FactorsTime Factors

Stichwörter der Autor:innen

all‐cause mortalitycomposite cardiovascular outcomecomposite limb outcomedialysispaclitaxel‐coated deviceperipheral endovascular intervention

Substanzen

Paclitaxel

Autor:innen und Institutionen

  • Cardiovascular Center Cathay General Hospital Taipei Taiwan.
  • School of Medicine, College of Life Science and Medicine National Tsing Hua University Hsinchu Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.
  • Division of Cardiology, Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.
  • Division of Cardiology, Department of Internal Medicine Mackay Memorial Hospital Hsinchu Branch Hsinchu Taiwan.
  • Division of Cardiology, Department of Internal Medicine Kaohsiung Chang Gung Memorial Hospital Kaohsiung Taiwan.

ORCID-Profile: Chen-Yu Huang, Hsu-Ping Wu, Wen-Jung Chung, Donna Shu-Han Lin, Po-Chao Hsu, Chun-Chi Chen, Jen-Kuang Lee, Chi-Hung Huang, Hsuan-Li Huang

Zitieren

APA

Huang, C. Y., Wu, H. P., Chung, W. J., Hsueh, S. K., Lin, D. S., Hsu, P. C., Chen, C. C., Lee, J. K., Huang, C. H., & Huang, H. L. (2026). Paclitaxel Efficacy in Dialysis‐Dependent Peripheral Artery Disease: A National Cohort Analysis. Journal of the American Heart Association, 15(14). https://doi.org/10.1161/jaha.126.050231

Vancouver

Huang CY, Wu HP, Chung WJ, Hsueh SK, Lin DS, Hsu PC, et al. Paclitaxel Efficacy in Dialysis‐Dependent Peripheral Artery Disease: A National Cohort Analysis. Journal of the American Heart Association. 2026;15(14). doi:10.1161/jaha.126.050231

BibTeX
@article{Huang2026,
  author = {Huang, Chen-Yu and Wu, Hsu-Ping and Chung, Wen-Jung and Hsueh, Shu-Kai and Lin, Donna Shu-Han and Hsu, Po-Chao and Chen, Chun-Chi and Lee, Jen-Kuang and Huang, Chi-Hung and Huang, Hsuan-Li},
  title = {Paclitaxel Efficacy in Dialysis‐Dependent Peripheral Artery Disease: A National Cohort Analysis},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1161/jaha.126.050231}
}
Kostenlos starten →